Clinical Trial Update: Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update from Samsung Medical Center assessing revascularization strategies for patients with acute myocardial infarction and cardiogenic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Multivessel Coronary Artery Disease
• Myocardial Infarction

Snippet

Sponsor: Samsung Medical Center | Conditions: Cardiogenic Shock, Acute Myocardial Infarction | Phase 4 | Status: RECRUITING